Factor VII Antikörper
Kurzübersicht für Factor VII Antikörper (ABIN7673037)
Target
Alle Factor VII (F7) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- F7 antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- coagulation factor VII(serum prothrombin conversion accelerator)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:2000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Haltbarkeit
- 12 months
-
-
- Factor VII (F7) (Coagulation Factor VII (F7))
-
Andere Bezeichnung
- F7
-
Hintergrund
-
Synonyms: Coagulation factor VII|Proconvertin|Serum prothrombin conversion accelerator (SPCA)|Factor VII light chain|Factor VII heavy chain|F7
Background: Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium.
-
Molekulargewicht
- 49-55 kDa
-
Gen-ID
- 2155
-
UniProt
- P08709
-
Pathways
- Response to Growth Hormone Stimulus, Platelet-derived growth Factor Receptor Signaling
Target
-